Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05377216 · ClinicalTrials.gov registry record · Early Phase 1

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

A Early Phase 1 study of Ventricular Tachycardia, sponsored by University of Pennsylvania.

Recruiting
Registry status
Early Phase 1
Development phase
20
Enrollment target
1
Study location

NCT05377216 is a Early Phase 1 study of Ventricular Tachycardia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 20 participants, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05377216, a Early Phase 1 study of Ventricular Tachycardia, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Conditions Studied

Ventricular Tachycardia

Interventions

  • DRUG Stellate Ganglion Block

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-09-01
Est. Completion 2027-07-01
Phase Early Phase 1

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05377216

The ClinicalTrials.gov registry entry for NCT05377216 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Stellate Ganglion Block is the first listed.

NCT05377216 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05377216 about?

NCT05377216 is a clinical study titled "Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation". Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

What is the current status of trial NCT05377216?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2022-09-01. Estimated completion is 2027-07-01.

What conditions does trial NCT05377216 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT05377216?

The interventions under investigation include: Stellate Ganglion Block (DRUG).

Who is sponsoring clinical trial NCT05377216?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05377216 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.